What is the typical dosing regimen for mirtazapine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mirtazapine Dosing

Start mirtazapine at 15 mg once daily at bedtime, and if inadequate response occurs, increase up to a maximum of 45 mg daily, with dose changes made no more frequently than every 1-2 weeks. 1

Initial Dosing

  • Begin with 15 mg once daily, administered orally in the evening prior to sleep 1
  • This starting dose is supported by FDA labeling and should be maintained for at least 1-2 weeks before considering dose adjustment 1
  • The evening timing capitalizes on mirtazapine's sedating properties, which can improve sleep disturbances often present in depression 2, 3

Dose Titration

  • If patients do not have adequate response to 15 mg, increase the dose up to a maximum of 45 mg per day 1
  • Dose changes should not be made in intervals of less than 1-2 weeks to allow sufficient time for evaluation of response 1
  • The American College of Physicians recommends assessing therapeutic response and adverse effects within 1-2 weeks of treatment initiation, with treatment modification strongly recommended if inadequate response occurs within 6-8 weeks 2

Dosing Adjustments for Drug Interactions

  • With strong CYP3A inducers (carbamazepine, phenytoin, rifampin): Increase mirtazapine dose as needed; conversely, decrease dose if the inducer is discontinued 1
  • With strong CYP3A4 inhibitors (ketoconazole, clarithromycin): Decrease mirtazapine dose; increase if the inhibitor is discontinued 1
  • With cimetidine: Decrease mirtazapine dose during concomitant use; increase if cimetidine is discontinued 1

Special Populations

  • Hepatic or renal impairment: Oral clearance decreases by approximately 30% with liver or moderate renal impairment, and by 50% with severe renal impairment 4
  • Elderly and female patients: These populations show higher plasma concentrations and may require more cautious dosing 4

Duration of Treatment

  • Continue treatment for 4-9 months after satisfactory response in patients with a first episode of major depressive disorder 2
  • For patients with 2 or more episodes of depression, even longer duration of therapy may be beneficial 2

Discontinuation

  • Gradually reduce the dosage rather than stopping abruptly whenever possible to minimize withdrawal symptoms 1
  • Screen patients for bipolar disorder, mania, or hypomania prior to initiating treatment 1
  • At least 14 days must elapse between discontinuation of an MAOI and initiation of mirtazapine, and vice versa 1

Clinical Advantages Supporting This Dosing

  • Mirtazapine has a faster onset of action than some SSRIs (fluoxetine, paroxetine, sertraline), with sleep disturbances and anxiety symptoms potentially improving in the first week 2, 3
  • The 20-40 hour elimination half-life supports once-daily dosing 3, 4
  • It is particularly suitable for patients with depression accompanied by insomnia or weight loss due to its sleep-promoting and appetite-stimulating properties 2, 5

References

Guideline

Mirtazapine Treatment Guidelines for Major Depressive Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacokinetics of mirtazapine.

Clinical pharmacokinetics, 2000

Guideline

Mirtazapine Dosing and Clinical Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.